Lizhong Zhang
Lizhong Zhang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Amit Mogha
Department of In Vivo and In Vitro Pharmacology, Alexion, AstraZeneca Rare Disease, Boston, MA, USA
1 shared publicationAndre Marozsan
Department of Preclinical Pharmacology, Alexion, AstraZeneca Rare Disease, Boston, MA, USA
1 shared publicationCatherine A. Brownstein
Manton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA
1 shared publicationCuishan Huang
Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, China
1 shared publication- David H. Kohn
Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI
1 shared publication - Genevieve E. Romanowicz
Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, USA
1 shared publication
Latest Publications
- Open Access
- 15 July 2025
- Published by Elsevier in Neuroscience Research
- Vol. 218, 104940
Asfotase alfa restores PLP-dependent GABA, cystathionine, and amino acid metabolism in a mouse model of hypophosphatasia
- 15 July 2025
- Published by Elsevier in Neuroscience Research
- Vol. 218, 104940
Open AccessAsfotase alfa restores PLP-dependent GABA, cystathionine, and amino acid metabolism in a mouse model of hypophosphatasia
- 28 August 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 187, 409-421
Beyond bone volume: Understanding tissue-level quality in healing of maxillary vs. femoral defects
- 28 August 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 187, 409-421
Beyond bone volume: Understanding tissue-level quality in healing of maxillary vs. femoral defects
- Open Access
- 16 February 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 33, 55-69
Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway
- 16 February 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 33, 55-69
Open AccessPuerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway